An abnormal chromosome known as the Philadelphia chromosome is seen in 90 percent of those with CML.
Bone marrow transplantation (BMT) is in the early 2000s becoming the treatment of choice for CML because it has the possibility of curing the illness.
Chronic myelogenous leukemia (CML), by contrast, may progress to a more acute form.
In chronic myelogenous leukemia (CML ), the primary genetic process has been characterized.
In chronic myelogenous leukemia (CML), the cells that are affected are the granulocytes.
In chronic myeloid leukemia (CML), the treatment of choice is bone marrow transplantation.
In CML, if bone marrow transplantation is performed within one to three years of diagnosis, 50 to 60 percent of the patients survive three years or more.
In general, chemotherapy is the standard approach to both CLL and CML.
In the acute phase of CML, aggressive chemotherapy is given.
In the early stages of chronic myeloid leukemia (CML), the symptoms are more or less similar to CLL.
Professor Junia V. Melo has a longstanding interest in the molecular mechanisms underlying the malignant phenotype of CML.
True to her word, Verity pitched up at my office ready to ' dish the dirt ' on the CML.